nference and Cedars-Sinai Collaboration
In a landmark announcement on November 20, 2026, nference revealed a long-term partnership with Cedars-Sinai aimed at revolutionizing clinical research through the development of an AI-enabled platform. This groundbreaking collaboration seeks to create a secure environment for researchers to analyze a vast array of de-identified clinical data, enriching the scientific understanding of health and disease.
Advancing Healthcare with AI
Dr. Venky Soundararajan, Founder and co-CEO of nference, emphasized that understanding health intricately involves linking diverse medical data across various modalities and timelines. "We are establishing a unique foundation for whole-body spatial intelligence that will enable researchers to connect disparate and unstructured data sources," he stated. The goal is to address complex scientific queries effectively and consequently deliver innovative solutions for the global patient population.
The proposed platform utilizes nference’s advanced federated software, which prioritizes patient privacy while also harmonizing diverse types of medical data. This innovation opens doors to longitudinal studies where physician-adjudicated data can offer rigorous research-ready information across numerous therapeutic and diagnostic sectors. The scope of the data involved includes everything from clinical notes and lab results to diagnostic imaging and genomic information, with a research focus on over 5 million patients’ records built over more than a decade.
Empowering Research and Innovation
Dr. Sumeet Chugh, Vice Dean and Chief AI Health Research Officer at Cedars-Sinai, expressed optimism regarding the partnership, explaining that the platform is designed to provide researchers and clinicians with groundbreaking insights. “We anticipate that our collaboration with nference will yield novel methods for learning from the collective experiences in patient care, consequently validating scientific hypotheses and expediting biomedical discoveries.”
This state-of-the-art platform is curated to support a range of activities from investigator-led studies and educational purposes to industry collaborations in life sciences. It also aims to equip Cedars-Sinai's researchers and innovators with the tools necessary for developing and assessing new AI models. These advancements can inform specialized areas such as drug discovery, clinical trial design, and diagnostic methods of the future.
nference: A Leader in Healthcare Superintelligence
nference is dedicated to creating a superintelligent infrastructure that facilitates biomedical discovery and clinical research. The company has consistently worked to transform decades of longitudinal clinical data into actionable research evidence by leveraging multimodal AI technologies. This includes synthesizing updated evidence from an extensive database of clinical notes, laboratory tests, and patient metrics.
The company's commitment to establishing strategic partnerships with leading academic medical institutions, like Mayo Clinic and Duke Health, underscores their ambition to set a gold standard in whole-body spatial computing.
With the collaborative efforts between nference and Cedars-Sinai, the healthcare community anticipates a significant advancement in the understanding of diseases, leading to enhanced patient outcomes and transformational innovations in clinical care. For further details about nference’s pioneering initiatives, visit their official website at
www.nference.com.